Literature DB >> 21957151

IL-13 receptor α1 differentially regulates aeroallergen-induced lung responses.

Marc E Rothenberg1, Ting Wen, Dana Shik, Eric T Cole, Melissa M Mingler, Ariel Munitz.   

Abstract

IL-13 and IL-4 are hallmark cytokines of Th2-associated diseases including asthma. Recent studies revealed that IL-13Rα1 regulates asthma pathogenesis by mediating both IL-4- and IL-13-mediated responses. Nonetheless, the relative contribution of each cytokine in response to aeroallergen challenge and the degree of functional dichotomy between IL-4 and IL-13 in asthma remains unclear. Consistent with prior publications, we demonstrate that IL-13Rα1 regulates aeroallergen-induced airway resistance and mucus production but not IgE and Th2 cytokine production. We demonstrate that aeroallergen-induced eosinophil recruitment and chemokine production were largely dependent on IL-13Rα1 after Aspergillus but not house dust mite (HDM) challenges. Notably, Aspergillus-challenged mice displayed increased IL-13Rα1-dependent accumulation of dendritic cell subsets into lung-draining lymph nodes in comparison with HDM-challenged mice. Comparison of IL-4 and IL-13 levels in the different experimental models revealed increased IL-4/IL-13 ratios after HDM challenge, likely explaining the IL-13Rα1-independent eosinophilia and chemokine production. Consistently, eosinophil adoptive transfer experiments revealed near ablation of lung eosinophilia in response to Aspergillus in Il13ra1(-/-) mice, suggesting that Aspergillus-induced lung eosinophil recruitment is regulated by IL-13-induced chemokine production rather than altered IL-13 signaling in eosinophils. Furthermore, the near complete protection observed in Il13ra1(-/-) mice in response to Aspergillus challenge was dependent on mucosal sensitization, as alum/Aspergillus-sensitized mice that were rechallenged with Aspergillus developed IL-13Rα1-independent eosinophilia although other asthma parameters remained IL-13Rα1 dependent. These results establish that IL-13Rα1 is required for aeroallergen-induced airway resistance and that allergen-induced chemokine production and consequent eosinophilia is dictated by the balance between IL-4 and IL-13 production in situ.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21957151      PMCID: PMC3197875          DOI: 10.4049/jimmunol.1004159

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

1.  Molecular mimicry as the key to the dominance of the house dust mite allergen Der p 2.

Authors:  Wayne R Thomas
Journal:  Expert Rev Clin Immunol       Date:  2009-05       Impact factor: 4.473

Review 2.  The eosinophil.

Authors:  Marc E Rothenberg; Simon P Hogan
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

Review 3.  Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma.

Authors:  Douglas A Kuperman; Robert P Schleimer
Journal:  Curr Mol Med       Date:  2008-08       Impact factor: 2.222

Review 4.  Biology of lung dendritic cells at the origin of asthma.

Authors:  Bart N Lambrecht; Hamida Hammad
Journal:  Immunity       Date:  2009-09-18       Impact factor: 31.745

Review 5.  Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies.

Authors:  Joseph D Sherrill; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2011-05-13       Impact factor: 10.793

6.  Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta).

Authors:  F Levi-Schaffer; E Garbuzenko; A Rubin; R Reich; D Pickholz; P Gillery; H Emonard; A Nagler; F A Maquart
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

7.  Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis.

Authors:  Carine Blanchard; Emily M Stucke; Karen Burwinkel; Julie M Caldwell; Margaret H Collins; Annette Ahrens; Bridget K Buckmeier; Sean C Jameson; Allison Greenberg; Ajay Kaul; James P Franciosi; Jonathan P Kushner; Lisa J Martin; Philip E Putnam; J Pablo Abonia; Suzanne I Wells; Marc E Rothenberg
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

Review 8.  Mechanisms of asthma.

Authors:  William W Busse; Lanny J Rosenwasser
Journal:  J Allergy Clin Immunol       Date:  2003-03       Impact factor: 10.793

9.  Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism.

Authors:  Anil Mishra; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

Review 10.  A closer look at chemokines and their role in asthmatic responses.

Authors:  Joost J Smit; Nicholas W Lukacs
Journal:  Eur J Pharmacol       Date:  2006-02-07       Impact factor: 4.432

View more
  18 in total

1.  Resistin-like molecule-α regulates IL-13-induced chemokine production but not allergen-induced airway responses.

Authors:  Ariel Munitz; Eric T Cole; Danielle Karo-Atar; Fred D Finkelman; Marc E Rothenberg
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-12       Impact factor: 6.914

2.  The extracellular and transmembrane domains of the γC and interleukin (IL)-13 receptor α1 chains, not their cytoplasmic domains, dictate the nature of signaling responses to IL-4 and IL-13.

Authors:  Nicola M Heller; Xiulan Qi; Franck Gesbert; Achsah D Keegan
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

Review 3.  The differential expression of IL-4 and IL-13 and its impact on type-2 immunity.

Authors:  Katherine Bao; R Lee Reinhardt
Journal:  Cytokine       Date:  2015-06-11       Impact factor: 3.861

4.  CD300f associates with IL-4 receptor α and amplifies IL-4-induced immune cell responses.

Authors:  Itay Moshkovits; Danielle Karo-Atar; Michal Itan; Hadar Reichman; Perri Rozenberg; Netali Morgenstern-Ben-Baruch; Dana Shik; Aroa Ejarque-Ortiz; Alon Y Hershko; Linjie Tian; John E Coligan; Joan Sayós; Ariel Munitz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

5.  Regulatory effects of IL-15 on allergen-induced airway obstruction.

Authors:  Sathisha Upparahalli Venkateshaiah; Xiang Zhu; Priya Rajavelu; Rituraj Niranjan; Murli Manohar; Alok K Verma; Joseph A Lasky; Anil Mishra
Journal:  J Allergy Clin Immunol       Date:  2017-06-09       Impact factor: 10.793

6.  Role of IL-18-transformed CD274-expressing eosinophils in promoting airway obstruction in experimental asthma.

Authors:  Anil Mishra; Dewan Majid; Hemanth Kumar Kandikattu; Chandra Sekhar Yadavalli; Sathisha Upparahalli Venkateshaiah
Journal:  Allergy       Date:  2021-12-03       Impact factor: 14.710

7.  IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages.

Authors:  Ashish Bhattacharjee; Meenakshi Shukla; Valentin P Yakubenko; Anny Mulya; Suman Kundu; Martha K Cathcart
Journal:  Free Radic Biol Med       Date:  2012-11-01       Impact factor: 7.376

8.  Interleukin-13 Receptor α1-Dependent Responses in the Intestine Are Critical to Parasite Clearance.

Authors:  Rex Sun; Joseph F Urban; Luigi Notari; Tim Vanuytsel; Kathleen B Madden; Jennifer A Bohl; Thirumalai R Ramalingam; Thomas A Wynn; Aiping Zhao; Terez Shea-Donohue
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

9.  Mig-6 deficiency cooperates with oncogenic Kras to promote mouse lung tumorigenesis.

Authors:  Jian Liu; Sung-Nam Cho; San-Pin Wu; Nili Jin; Seyed Javad Moghaddam; Jennifer L Gilbert; Ignacio Wistuba; Francesco J DeMayo
Journal:  Lung Cancer       Date:  2017-08-05       Impact factor: 5.705

10.  Homologous recombination into the eosinophil peroxidase locus generates a strain of mice expressing Cre recombinase exclusively in eosinophils.

Authors:  Alfred D Doyle; Elizabeth A Jacobsen; Sergei I Ochkur; Lian Willetts; Kelly Shim; Joseph Neely; Jake Kloeber; Will E Lesuer; Ralph S Pero; Paige Lacy; Redwan Moqbel; Nancy A Lee; James J Lee
Journal:  J Leukoc Biol       Date:  2013-04-29       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.